Filing Details

Accession Number:
0001209191-20-013478
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-27 17:34:52
Reporting Period:
2020-02-26
Accepted Time:
2020-02-27 17:34:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382101 Sutro Biopharma Inc. STRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326592 Trevor Hallam C/O Sutro Biopharma, Inc.
310 Utah Avenue, Suite 150
South San Francisco CA 94080
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-26 975 $10.47 22,640 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.13 to $10.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.